Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 100,200 shares, a decrease of 26.4% from the October 15th total of 136,100 shares. Based on an average daily volume of 472,700 shares, the short-interest ratio is presently 0.2 days. Currently, 16.0% of the shares of the stock are sold short.

Wall Street Analyst Weigh In

Separately, LADENBURG THALM/SH SH initiated coverage on Autonomix Medical in a report on Tuesday, September 3rd. They set a “buy” rating and a $28.00 price objective for the company.

Autonomix Medical Stock Performance

NASDAQ AMIX opened at $10.26 on Thursday. Autonomix Medical has a 1-year low of $7.51 and a 1-year high of $152.00. The company has a 50 day moving average of $12.61 and a 200-day moving average of $23.03. The company has a quick ratio of 9.27, a current ratio of 4.26 and a debt-to-equity ratio of 0.36.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($2.80) earnings per share for the quarter. As a group, analysts expect that Autonomix Medical will post -10 earnings per share for the current year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.